Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase

被引:84
|
作者
Burke, DH
Scates, L
Andrews, K
Gold, L
机构
[1] UNIV COLORADO, DEPT MOL CELLULAR & DEV BIOL, BOULDER, CO 80309 USA
[2] NEXSTAR PHARMACEUT INC, BOULDER, CO 80301 USA
关键词
reverse transcriptase; RNA-protein interactions; SELEX; RNA pseudoknots; nucleic acid structure;
D O I
10.1006/jmbi.1996.0667
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The reverse transcriptase (RT) of the human immunodeficiency virus (HIV) is a proven target for therapeutic intervention of HIV infections. We have found several new RNA inhibitors of HIV-1 RT that differ significantly from the pseudoknot ligands found previously, along with a wide variety of pseudoknot variants. One pseudoknot variant and three novel ligands were studied in more detail. Each specifically inhibits DNA polymerization by HIV RT (half-maximal inhibition at 0.3 to 20 nM inhibitor), but not that of RTs derived from MMLV or AMV. The minimal binding element of each isolate was determined by deletion analysis and by gel electrophoresis of protein-bound, partially alkaline-hydrolyzed RNA. Truncations of three of the isolates bound nearly as well as (or better than) the parental sequences, while most deletions in the fourth caused substantial disruption of binding. The truncated versions of two isolates were subjected to six rounds of secondary SELEX after resynthesizing them mutagenically. Patterns of conserved and covarying nucleotides yielded structural models consistent with 5' and 3' boundary determinations for these molecules. Among the four isolates studied in detail, the first is confirmed as being a pseudoknot, albeit with substantial structural differences as compared to the canonical pseudoknots identified previously. The second forms a stem-loop structure with additional flanking sequences required for binding. Tentative structural models for the other two isolates are presented. The minimal fully active truncations of each of these four isolates compete with each other and with a classical RNA pseudoknot for binding to HIV RT, suggesting that they all recognize the same or overlapping sites on the protein, in spite of their apparently dissimilar structures. We model their interactions with RT as mimicking the 40 to 45 degree bend in dsDNA co-crystallized with RT. (C) 1996 Academic Press Limited
引用
收藏
页码:650 / 666
页数:17
相关论文
共 50 条
  • [41] Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous
    Wilson, JE
    Wright, LL
    Martin, JL
    Haire, SE
    Ray, PH
    Painter, GR
    Furman, PA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (01): : 20 - 30
  • [42] Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase
    Zhang, Zhijun
    Walker, Michelle
    Xu, Wen
    Shim, Jae Hoon
    Girardet, Jean-Luc
    Hamatake, Robert K.
    Hong, Zhi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2772 - 2781
  • [43] Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1
    Herschhorn, Alon
    Hizi, Amnon
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) : 5702 - 5713
  • [44] Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV
    Balzarini, J
    Camarasa, MJ
    Pérez-Pérez, MJ
    San-Fléix, A
    Velázquez, S
    Perno, CF
    De Clercq, E
    Anderson, JN
    Karlsson, A
    JOURNAL OF VIROLOGY, 2001, 75 (13) : 5772 - 5777
  • [45] Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance development
    DeClercq, E
    MEDICINAL RESEARCH REVIEWS, 1996, 16 (02) : 125 - 157
  • [46] SUPPRESSIVE EFFECT OF POLYOXOMETALATES ON THE CYTOPATHOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INVITRO AND THEIR INHIBITORY ACTIVITY AGAINST HIV-1 REVERSE-TRANSCRIPTASE
    INOUYE, Y
    TOKUTAKE, Y
    KUNIHARA, J
    YOSHIDA, T
    YAMASE, T
    NAKATA, A
    NAKAMURA, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (03) : 805 - 807
  • [47] Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: Retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase
    Borkow, G
    Barnard, J
    Nguyen, TM
    Belmonte, A
    Wainberg, MA
    Parniak, MA
    JOURNAL OF VIROLOGY, 1997, 71 (04) : 3023 - 3030
  • [48] Emerging reverse transcriptase inhibitors for HIV-1 infection
    Rai, Mohammad A.
    Pannek, Sam
    Fichtenbaum, Carl J.
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (02) : 149 - 157
  • [49] HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors
    Spence, RA
    Anderson, KS
    Johnson, KA
    BIOCHEMISTRY, 1996, 35 (03) : 1054 - 1063
  • [50] SPECIFIC HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
    DEBYSER, Z
    PAUWELS, R
    ANDRIES, K
    DE CLERCQ, E
    JOURNAL OF ENZYME INHIBITION, 1992, 6 (01): : 47 - 53